FBXO21 and acute myeloid leukemia: In contrast, ARF6 protein abundance was unaltered in either shNTC or shFBXO21 KD following MG132 suggesting it is likely not regulated in AML by proteasomal degradation and further confirming ARF6 is not a substrate of FBXO21.